Bayer AG (BAYRY)
7.39
+0.12
(+1.65%)
USD |
OTCM |
Apr 26, 16:00
Bayer Debt to Equity Ratio: 1.264 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.264 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 1.034 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 1.162 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 1.324 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.7964 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.3524 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.5877 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.7552 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.935 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.3293 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.4536 |
| September 30, 2012 | 0.5229 |
| June 30, 2012 | 0.5356 |
| March 31, 2012 | 0.5817 |
| December 31, 2011 | 0.5396 |
| September 30, 2011 | 0.5933 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
1.324
Maximum
Dec 2020
0.2937
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.2102 |
| InflaRx NV | 0.00 |
| MorphoSys AG | 12.71 |
| BioNTech SE | 0.0108 |
| Immatics NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 128.51B |
| Total Liabilities (Quarterly) | 91.95B |
| Shareholders Equity (Quarterly) | 36.40B |
| Current Ratio | 1.275 |
| Net Debt Paydown Yield | -25.38% |